In tandem with exemplary growth in the healthcare sector, China has started confronting with some consequential hazards in form of serious regulatory violations involving, besides many others, hospitals, pharmaceutical pricing and food and drug safety, which reportedly include contaminated milk powder and … Continue reading
Tag Archives: is
The Concept of Orphan Drugs for Orphan Diseases is Orphan in India
Though the percentage of patients suffering from ‘Rare Diseases’ in India is reportedly higher than the world average, unfortunately even today such cases get little help from our government. According to experts, diseases manifesting patients representing maximum 6 to 8 … Continue reading
Replication of ‘Old Paradigm’ of the developed pharmaceutical markets is unlikely to yield results in the evolving new paradigm of India
“Health leaps out of science and draws nourishment from the society around it” – Gunnar Myrdal (Swedish Nobel Laureate Economist) The success concoction of the global pharmaceutical industry for India, by and large, still remains to be sustained attempts in … Continue reading
The New Drug Policy is languishing in a labyrinth
Drug Price Control has remained the key feature of all Drug Policies of India, since their inception in early 70’s. Most of these policies continued to remain behind their times consistently, without any exception. That said, the Drug Policy 1994 … Continue reading
The Vaccine Market of India: A rejuvenation is in progress
Even in couple of decades back, ‘Vaccines Market’ in India did not use to be considered as a focus area by many pharmaceutical companies. Commoditization of this market with low profit margin and unpredictable interest of the government/the doctors towards … Continue reading
Encourage vaccine research and improve its access to demonstrate ‘prevention is better than cure’
Vaccines are one of the most successful and cost-effective public health interventions, which help preventing over 2 million deaths every year. The World Health Organization (WHO) defines vaccines as: “A vaccine is any preparation intended to produce immunity to a … Continue reading
Biologic Drugs: The hunt for the ‘Magic Bullets’ is on
The global pharmaceutical industry is now navigating its way through very cautiously while negotiating an unprecedented ‘patent cliff’, simultaneously with gradually drying-up R&D pipelines. This unique situation has triggered off several global mega Mergers and Acquisitions (M&A) not only involving … Continue reading
A National Regulatory Standard is necessary for MRs of the Indian Pharmaceutical Industry
Medical Representatives (MR) form the bedrock of business success, especially for the pharmaceutical industry in India. The Job of MRs is tough and high voltage one, laced with moments of elation and sprinkles of frustration, while generating prescription demand for … Continue reading